JOHANNESBURG, 10 February 2021 – Public health officials in South Africa have announced a change in plans in the inoculation of its citizens against COVID-19.
The Johnson & Johnson vaccine will be used to vaccinate health workers and other at-risk elderly South African, the country’s health minister, Zweli Mkhize, said Tuesday.
Officials expect to move forwardalthough the Johnson & Johnson vaccine has not yet been approved in South Africa.
The country’s vaccination plan was put on hold after tests showed that the AstraZeneca vaccine was less effective against the South African variant of the virus.
Doses of the Pfizer vaccine have also been secured for inoculation in South Africa.
Mkhize said South Africa is considering selling the doses of the AstraZeneca vaccines to another country.
At a press conference, Mkhize said his department is waiting to be advised by South African scientists on what exactly to do with the less effective doses.